Overview
Immune-mediated acquired neuromuscular junction disease is a group of conditions where the body's own immune system mistakenly attacks the connection point between nerves and muscles, called the neuromuscular junction. The most well-known condition in this group is myasthenia gravis, but it also includes Lambert-Eaton myasthenic syndrome and other related autoimmune disorders affecting this junction. In these diseases, the immune system produces antibodies that block, damage, or destroy the receptors or proteins at the neuromuscular junction, preventing normal communication between nerves and muscles. The main symptoms include muscle weakness that tends to get worse with activity and improve with rest. Commonly affected muscles include those controlling eye movement (causing drooping eyelids and double vision), facial expression, chewing, swallowing, and speaking. In more severe cases, the muscles used for breathing can be affected, which can become life-threatening. Weakness in the arms and legs can also occur, making everyday tasks like climbing stairs or lifting objects difficult. Treatment has improved significantly over the years. Options include medications that improve nerve-to-muscle signaling (such as pyridostigmine), immunosuppressive drugs (like prednisone, azathioprine, or mycophenolate), and newer targeted therapies. Plasma exchange and intravenous immunoglobulin (IVIg) can provide rapid but temporary relief during flare-ups. In some cases, surgical removal of the thymus gland (thymectomy) is recommended. Newer biologic therapies such as eculizumab, efgartigimod, and rozanolixizumab have been approved for certain forms of the disease, offering more targeted treatment options.
Key symptoms:
Drooping eyelids (ptosis)Double visionMuscle weakness that worsens with activityDifficulty chewing and swallowingSlurred or nasal speechWeakness in arms and legsDifficulty breathingFacial muscle weaknessNeck weakness or head dropFatigue that worsens throughout the dayDifficulty holding up the headTrouble climbing stairs or rising from a chairWeak grip strength
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Immune-mediated acquired neuromuscular junction disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Immune-mediated acquired neuromuscular junction disease at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Immune-mediated acquired neuromuscular junction disease.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Immune-mediated acquired neuromuscular junction disease.
Community
No community posts yet. Be the first to share your experience with Immune-mediated acquired neuromuscular junction disease.
Start the conversation →Latest news about Immune-mediated acquired neuromuscular junction disease
No recent news articles for Immune-mediated acquired neuromuscular junction disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific type of neuromuscular junction disease do I have, and which antibodies were found in my blood?,What treatment plan do you recommend, and what are the potential side effects?,Are there medications I should avoid because they could worsen my symptoms?,Should I be screened for thymus gland problems or cancer?,What should I do if I experience a sudden worsening of my breathing or swallowing?,Am I a candidate for newer biologic therapies or thymectomy?,How often will I need follow-up visits and blood tests to monitor my condition and medications?
Common questions about Immune-mediated acquired neuromuscular junction disease
What is Immune-mediated acquired neuromuscular junction disease?
Immune-mediated acquired neuromuscular junction disease is a group of conditions where the body's own immune system mistakenly attacks the connection point between nerves and muscles, called the neuromuscular junction. The most well-known condition in this group is myasthenia gravis, but it also includes Lambert-Eaton myasthenic syndrome and other related autoimmune disorders affecting this junction. In these diseases, the immune system produces antibodies that block, damage, or destroy the receptors or proteins at the neuromuscular junction, preventing normal communication between nerves and
How is Immune-mediated acquired neuromuscular junction disease inherited?
Immune-mediated acquired neuromuscular junction disease follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.